Search Results
… preparatory to phase III clinical trials in neurological disorders, Data and Safety Monitoring Boards Contact …
… Program Director at the National Institute of Neurological Disorders and Stroke. Her portfolio includes BRAIN …
Image
Amy Bany Adams, Ph.D.Deputy Director for Scientific Management and Operations
The Office of Scientific Management and Operations (OSMO) accelerates the advancement of neuroscience through proactive leadership, guidance, and comprehensive support, fostering the integration of science,…
Acting Chief of Staff, Division of Extramural Activities
Image
Immediate Office of the Director (DEA)
Division of Extramural Activities
Contact…
… diseases, including ultra-rare diseases, are neurological disorders, and 90% of rare childhood disorders have major neurological effects. 85% of rare and ultra-rare diseases are single gene disorders, making them excellent candidates for gene therapy. …
… of Use” (COU) and why is it critical for establishing the study design? The Context of Use for a Biomarker is “ a … should be able to test the biomarker using data/samples from patients undergoing the … additional input from review. Should I still apply if my biomarker proposal is focused on the same disease and for …
Referral Program Specialist
Image
Immediate Office of the Director (DEA)
Division of Extramural Activities
Contact
…
… Craig Blackstone at the National Institute of Neurological Disorders and Stroke, National Institutes of Health, … spastic paraplegias (HSPs) – a group of neurological disorders characterized by lower extremity spastic weakness. …
… in the context of Amyotrophic Lateral Sclerosis. Prior to joining NINDS, Dr. Hoye was a postdoctoral scholar at Duke … Her research interests broadly included understanding how impaired RNA metabolism contributes to neurological disease and dysfunction. Dr. Hoye joined the …
… of Neuroscience at National Institute of Neurological Disorders and Stroke ( NINDS ), where he manages a portfolio …